课题基金 / 基金详情

SHP-1 REGULATION OF THE KU SIGNALING PATHWAY

SHP-1 REGULATION OF THE KU SIGNALING PATHWAY
SHP-1 对 KU 信号通路的调节
批准号:
2746793
负责人:
Taolin Yi
金额:
$15.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 2003-12-31

项目摘要

项目成果

Taolin Yi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract) This application describes studies to investigate the mechanism underlying the regulation of cell growth by the protein tyrosine phosphatase SHP-1. SHP-1 is a SH2-domain containing tyrosine phosphatase that has been shown in a number of systems to negatively regulate receptor-mediated cell signaling pathways and therefore negatively regulate cell growth. It has been most extensively studied in the context of hematopoietic/cytokine receptors, FCgRIIB and MCH class I receptors expressed on NK cells, where SHP-1 is recruited to the tyrosine phosphorylated receptor and activated. The investigator has identified nuclear proteins that are associated with SHP-1 and has demonstrated that SHP-1 is found in the nucleus. Dr. Yi proposes to investigate: 1) the role of two C-terminal tyrosine residues in the nuclear localization of SHP-1; 2) the cell cycle dependence on the interaction of SHP-1 with its nuclear binding partners; and 3) the role of these binding partners in activating the phosphatase activity of SHP-1. Through these studies the investigator proposes to identify a nuclear function for SHP-1 that contributes to its role as a negative regulator of cell growth.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-Cancer Activities of PTPase Inhibitors
Anti-Cancer Activities of PTPase Inhibitors
Anti-Cancer Activities of PTPase Inhibitors
PTPases as Therapeutic Targets
海外基金